NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Tyra Biosciences, Inc. Common Stock Share Price Chart

O H L

Tyra Biosciences, Inc. Common Stock Performance Overview

Days Range
$24.59Low
$24.95High

Markets Today

Previous Close$24.43
Open$24.60
Volume139,726
Day's Range$24.59 - $24.95
52W Range$12.12 - $40.65
Market Cap$1.67 B

Historical Performance

1M Returns-6.18
3M Returns-13.74
6M Returns-35.80
1Y Returns+91.01
5Y Returns+22.70
10Y ReturnsNA

Tyra Biosciences, Inc. Common Stock Fundamentals

Market Cap$1.67 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.40
EPS TTM$-2.39
Quarterly Earnings Growth YOYN/A
PB Ratio4.11
EBITDA$-132.22 M
Profit MarginN/A
Market Cap$1.67 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.40
EPS TTM$-2.39
Quarterly Earnings Growth YOYN/A
PB Ratio4.11
EBITDA$-132.22 M
Profit MarginN/A

Tyra Biosciences, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$31.85 M-$31.45 M-$32.94 M-$36.52 M-$42.00 M-$49.00 M
EBITDA -$31.71 M-$31.31 M-$32.81 M-$36.38 M-$41.86 M-$48.87 M
Interest Expense $0$0$0$0$0$0
Depreciation $143.00 K$140.00 K$131.00 K$132.00 K$138.00 K$138.00 K
Income Before Tax -$28.15 M-$28.10 M-$29.87 M-$33.83 M-$39.30 M-$45.56 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$28.15 M-$28.10 M-$29.87 M-$33.83 M-$39.30 M-$45.56 M
Net Profit Margin ------

Tyra Biosciences, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $5.00 K$5.00 K$5.00 K$5.00 K$6.00 K$6.00 K
Reserve & Surplus -$278.77 M-$307.12 M-$336.98 M-$370.87 M-$410.46 M-$456.70 M
Non-Current Liabilities $5.70 M$5.58 M$5.46 M$5.34 M$5.21 M$5.08 M
Current Liabilities $14.25 M$13.77 M$15.88 M$18.09 M$19.26 M$24.62 M
Total Liabilities $19.94 M$19.35 M$21.34 M$23.43 M$24.46 M$29.70 M
Fixed Assets $1.52 M$1.41 M$1.35 M$1.31 M$1.22 M$1.17 M
Current Assets $324.57 M$302.15 M$281.22 M$265.45 M$394.61 M$366.97 M
Total Assets $343.48 M$321.50 M$301.85 M$282.61 M$412.04 M$383.36 M

Tyra Biosciences, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$28.15 M-$28.10 M-$29.87 M-$33.83 M-$39.30 M-$45.56 M
Operating Cash Flow -$25.46 M-$23.68 M-$22.38 M-$23.62 M-$32.57 M-$31.08 M
Investing Cash Flow $32.03 M$20.87 M-$14.81 M$34.38 M-$120.24 M$17.85 M
Financing Cash Flow $2.19 M$583.00 K$647.00 K$4.68 M$160.38 M$2.10 M
Change in Cash $8.76 M-$2.23 M-$36.54 M$15.44 M$7.57 M-$11.12 M

Tyra Biosciences, Inc. Common Stock Return Calculator

The Tyra Biosciences, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$12,557
Invested Amount$10,000
Est. Returns$2,557
Invest in USA Stock Today

About Tyra Biosciences, Inc. Common Stock

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

FAQs

Tyra Biosciences, Inc. Common Stock (TYRA) share price as of September 18, 2026 is $25.00. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Tyra Biosciences, Inc. Common Stock (TYRA) Share by opening an international trading account with Angel One.
Purchasing Tyra Biosciences, Inc. Common Stock (TYRA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Tyra Biosciences, Inc. Common Stock (TYRA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Tyra Biosciences, Inc. Common Stock (TYRA) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Tyra Biosciences, Inc. Common Stock on September 18, 2026, is $1.67 B.
Tyra Biosciences, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Tyra Biosciences, Inc. Common Stock (TYRA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91